Haruka Nishida
Overview
Explore the profile of Haruka Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tansou R, Kubo T, Nishida H, Nishimura Y, Mihara K, Yanagihara K, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001596
Programmed death 1 ligand (PD-L1), an important immune checkpoint molecule, is mainly expressed on cancer cells and has been shown to exert an immunosuppressive effect on T-cell function by binding...
2.
Ichinose T, Takasaki K, Takahashi Y, Hirano M, Nishida H, Hiraike H, et al.
Gynecol Oncol Rep
. 2025 Feb;
57:101673.
PMID: 39895895
Background: Lobular endocervical glandular hyperplasia (LEGH) is a benign cervical condition that has been proposed as a precursor lesion to minimal deviation adenocarcinoma (MDA), a rare but highly aggressive subtype...
3.
Takahashi Y, Sasamori Y, Higuchi R, Kaku A, Kumagai T, Watanabe S, et al.
PLoS One
. 2025 Jan;
20(1):e0311588.
PMID: 39774513
The incidence and mortality rates of cervical cancer are increasing among young Japanese women. In November 2021, the Japanese Ministry of Health, Labour, and Welfare reinstated the active recommendation of...
4.
Takasaki K, Ichinose T, Nishida H, Miyagawa Y, Hashimoto K, Watanabe S, et al.
J Ovarian Res
. 2024 Aug;
17(1):170.
PMID: 39182152
Background: Interval debulking surgery (IDS) following neoadjuvant chemotherapy is a treatment option for advanced ovarian cancer. Optimal surgery is required for better survival; however, while peritoneal washing cytology (PWC) has...
5.
Kataoka Y, Baba T, Ikenoue T, Matsuoka Y, Matsumoto J, Kumasawa J, et al.
Ann Clin Epidemiol
. 2024 Mar;
4(4):110-119.
PMID: 38505255
Background: We aimed to develop and externally validate a novel machine learning model that can classify CT image findings as positive or negative for SARS-CoV-2 reverse transcription polymerase chain reaction...
6.
Hashimoto K, Kumagai T, Nomura K, Miyagawa Y, Tago S, Takasaki K, et al.
Sci Rep
. 2023 Oct;
13(1):17052.
PMID: 37816765
More specific screening systems for cervical cancer may become necessary as the human papillomavirus (HPV) vaccine becomes more widespread. Although p16/Ki-67 dual-staining cytology has several advantages, it requires advanced diagnostic...
7.
Mizu D, Matsuoka Y, Nishida H, Sakatani T, Teramoto S, Ariyoshi K
Acute Med Surg
. 2023 Jun;
10(1):e863.
PMID: 37362033
Aim: To examine the causes of patients with severely impaired consciousness and the clinical characteristics in prehospital settings that are useful for differential diagnosis, especially stroke. Methods: We retrospectively examined...
8.
Takasaki K, Ichinose T, Miyagawa Y, Fukui S, Hashimoto K, Nishida H, et al.
J Ovarian Res
. 2023 Jun;
16(1):112.
PMID: 37316921
Background: Granulosa cell tumors (GCTs) account for approximately 2% of ovarian malignancies and are considered a rare type of ovarian cancer. GCTs are characterized by irregular genital bleeding after menopause...
9.
Matsuura Y, Nishida H, Kosaka T, Shigekawa K, Takasaki K, Ichinose T, et al.
Front Oncol
. 2023 Feb;
12:1079716.
PMID: 36741713
Background: Lenvatinib-pembrolizumab combination (LEAP) is an approved therapy in Japan for advanced endometrial cancer, based on the data from the KEYNOTE-775 clinical trial. We report a case of posterior reversible...
10.
Nishida H, Takahashi Y, Takehara K, Yatsuki K, Ichinose T, Ishida T, et al.
Pathogens
. 2023 Jan;
12(1).
PMID: 36678442
infections may occur in multiple organs, including the lungs, lymph nodes, peritoneal cavity, and genitourinary systems. This disease results in significant ascites, the swelling of lymph nodes, and elevated tumor...